ELV
Elevance Health, Inc.
Company overview
- Market capitalization
- $85.57B
- Employees
- 96,129
- Latest publication
- 2026-09-29
About Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Financial statements
Income YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Total Revenue | 100,655,000,000USD |
| Total Operating Expenses | 95,471,000,000USD |
| Operating Income | 3,849,000,000USD |
| Total Other Income Expense Net | 392,000,000USD |
| Interest Expense | 721,000,000USD |
| Income Before Tax | 4,241,000,000USD |
| Income Tax Expense | 1,027,000,000USD |
| Net Income | 3,214,000,000USD |
| Minority Interest | -13,000,000USD |
| Net Income Applicable To Common Shares | 3,227,000,000USD |
| Source | DisclosureDeterministicFinal |
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 50,474,000,000USD | 50,181,000,000USD | 49,747,000,000USD | 50,711,000,000USD | 49,776,000,000USD | 48,891,000,000USD | 45,145,000,000USD | 43,646,000,000USD |
| Selling General Administrative | 5,547,000,000USD | 6,330,000,000USD | — | — | 1,838,000,000USD | — | 1,838,000,000USD | — |
| Other Operating Expenses | 110,000,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 48,063,000,000USD | 6,442,000,000USD | 11,101,000,000USD | 10,814,000,000USD | 10,437,000,000USD | 10,438,000,000USD | 10,484,000,000USD | 10,048,000,000USD |
| Operating Income | 1,763,000,000USD | 2,661,000,000USD | 581,000,000USD | 1,757,000,000USD | 2,633,000,000USD | 3,141,000,000USD | 1,712,000,000USD | 3,026,000,000USD |
| Total Other Income Expense Net | 174,000,000USD | -357,000,000USD | -366,000,000USD | -351,000,000USD | -341,000,000USD | -344,000,000USD | -339,000,000USD | -40,000,000USD |
| Interest Expense | 364,000,000USD | 357,000,000USD | 366,000,000USD | 351,000,000USD | 341,000,000USD | 344,000,000USD | 300,000,000USD | 280,000,000USD |
| Income Before Tax | 1,937,000,000USD | 2,304,000,000USD | 215,000,000USD | 1,406,000,000USD | 2,292,000,000USD | 2,797,000,000USD | 1,373,000,000USD | 2,986,000,000USD |
| Income Tax Expense | 483,000,000USD | 544,000,000USD | -331,000,000USD | 219,000,000USD | 548,000,000USD | 613,000,000USD | 365,000,000USD | 685,000,000USD |
| Net Income | 1,454,000,000USD | 1,764,000,000USD | 547,000,000USD | 1,189,000,000USD | 1,743,000,000USD | 2,183,000,000USD | 1,016,000,000USD | 2,300,000,000USD |
| Minority Interest | -9,000,000USD | 4,000,000USD | 1,000,000USD | 2,000,000USD | -1,000,000USD | -1,000,000USD | 8,000,000USD | -1,000,000USD |
| Net Income Applicable To Common Shares | 1,463,000,000USD | — | 547,000,000USD | 1,189,000,000USD | 1,743,000,000USD | 2,183,000,000USD | — | — |
| Cost Of Revenue | — | 41,078,000,000USD | 38,065,000,000USD | 38,140,000,000USD | 36,706,000,000USD | 35,312,000,000USD | 32,949,000,000USD | 30,572,000,000USD |
| Gross Profit | — | 9,103,000,000USD | 11,682,000,000USD | 12,571,000,000USD | 13,070,000,000USD | 13,579,000,000USD | 12,196,000,000USD | 13,074,000,000USD |
| Unclassified Operating Expenses | — | 112,000,000USD | 11,101,000,000USD | 10,814,000,000USD | 6,168,000,000USD | 10,438,000,000USD | 6,215,000,000USD | 10,048,000,000USD |
| Net Interest Income | — | -357,000,000USD | -366,000,000USD | -351,000,000USD | -341,000,000USD | -344,000,000USD | -300,000,000USD | -280,000,000USD |
| Tax Provision | — | 544,000,000USD | -331,000,000USD | 219,000,000USD | 548,000,000USD | 613,000,000USD | 365,000,000USD | 685,000,000USD |
| Net Income From Continuing Ops | — | 1,760,000,000USD | 546,000,000USD | 1,187,000,000USD | 1,744,000,000USD | 2,184,000,000USD | 1,008,000,000USD | 2,301,000,000USD |
| Ebit | — | 2,661,000,000USD | 581,000,000USD | 1,757,000,000USD | 2,633,000,000USD | 3,141,000,000USD | 1,673,000,000USD | 3,266,000,000USD |
| Ebitda | — | 2,773,000,000USD | 987,000,000USD | 2,144,000,000USD | 3,013,000,000USD | 3,514,000,000USD | 2,002,000,000USD | 3,601,000,000USD |
| Depreciation And Amortization | — | 112,000,000USD | 406,000,000USD | 387,000,000USD | 380,000,000USD | 373,000,000USD | 329,000,000USD | 335,000,000USD |
| Reconciled Depreciation | — | 354,000,000USD | 406,000,000USD | 387,000,000USD | 380,000,000USD | 373,000,000USD | 329,000,000USD | 335,000,000USD |
| Interest Income | — | — | 366,000,000USD | 351,000,000USD | 341,000,000USD | 344,000,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | 2,431,000,000USD | — | 2,431,000,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 199,125,000,000USD | 176,810,000,000USD | 171,340,000,000USD | 156,595,000,000USD | 138,639,000,000USD | 121,867,000,000USD | 104,213,000,000USD | 92,105,000,000USD |
| Cost Of Revenue | 148,223,000,000USD | 127,567,000,000USD | 124,330,000,000USD | 116,642,000,000USD | 102,645,000,000USD | 88,045,000,000USD | 81,786,000,000USD | 71,895,000,000USD |
| Gross Profit | 50,902,000,000USD | 49,243,000,000USD | 47,010,000,000USD | 39,953,000,000USD | 35,994,000,000USD | 33,822,000,000USD | 22,427,000,000USD | 20,210,000,000USD |
| Unclassified Operating Expenses | 42,790,000,000USD | 40,355,000,000USD | 38,265,000,000USD | 13,816,000,000USD | 27,041,087,000USD | 8,661,000,000USD | 2,330,000,000USD | 353,000,000USD |
| Total Operating Expenses | 42,790,000,000USD | 40,355,000,000USD | 38,265,000,000USD | 31,502,000,000USD | 27,048,000,000USD | 26,111,000,000USD | 15,694,000,000USD | 14,373,000,000USD |
| Operating Income | 8,112,000,000USD | 8,888,000,000USD | 8,745,000,000USD | 8,451,000,000USD | 8,946,000,000USD | 7,711,000,000USD | 6,733,000,000USD | 5,837,000,000USD |
| Interest Income | 1,402,000,000USD | 1,185,000,000USD | 1,030,000,000USD | 851,000,000USD | 798,000,000USD | 784,000,000USD | 746,000,000USD | 753,000,000USD |
| Interest Expense | 1,402,000,000USD | 1,185,000,000USD | 1,030,000,000USD | 851,000,000USD | 798,000,000USD | 784,000,000USD | 746,000,000USD | 753,000,000USD |
| Net Interest Income | -1,402,000,000USD | -1,185,000,000USD | -1,000,000,000USD | -851,000,000USD | -798,000,000USD | -784,000,000USD | -746,000,000USD | -753,000,000USD |
| Income Before Tax | 6,710,000,000USD | 7,904,000,000USD | 7,715,000,000USD | 7,600,000,000USD | 7,925,000,000USD | 6,238,000,000USD | 5,985,000,000USD | 5,068,000,000USD |
| Income Tax Expense | 1,049,000,000USD | 1,933,000,000USD | 1,724,000,000USD | 1,712,000,000USD | 1,830,000,000USD | 1,666,000,000USD | 1,178,000,000USD | 1,318,000,000USD |
| Tax Provision | 1,049,000,000USD | 1,933,000,000USD | 1,760,000,000USD | 1,750,000,000USD | 1,830,000,000USD | 1,666,000,000USD | 1,178,000,000USD | 1,318,000,000USD |
| Net Income | 5,662,000,000USD | 5,980,000,000USD | 5,987,000,000USD | 5,894,000,000USD | 6,104,000,000USD | 4,572,000,000USD | 4,807,000,000USD | 3,750,000,000USD |
| Net Income From Continuing Ops | 5,661,000,000USD | 5,971,000,000USD | 6,168,000,000USD | 6,019,000,000USD | 6,095,000,000USD | 4,572,000,000USD | 7,163,000,000USD | 6,386,000,000USD |
| Ebit | 8,112,000,000USD | 9,089,000,000USD | 8,745,000,000USD | 8,451,000,000USD | 8,723,000,000USD | 7,022,000,000USD | 6,731,000,000USD | 5,821,000,000USD |
| Ebitda | 9,658,000,000USD | 10,482,000,000USD | 10,490,000,000USD | 10,126,000,000USD | 10,025,000,000USD | 8,176,000,000USD | 7,864,000,000USD | 6,953,000,000USD |
| Depreciation And Amortization | 1,546,000,000USD | 1,393,000,000USD | 1,745,000,000USD | 1,675,000,000USD | 1,302,000,000USD | 1,154,000,000USD | 1,133,000,000USD | 1,132,000,000USD |
| Reconciled Depreciation | 1,546,000,000USD | 1,393,000,000USD | 1,794,000,000USD | 1,675,000,000USD | 1,302,000,000USD | 1,154,000,000USD | 1,133,000,000USD | 1,132,000,000USD |
| Total Other Income Expense Net | -1,402,000,000USD | -984,000,000USD | -1,030,000,000USD | -851,000,000USD | -1,021,000,000USD | -1,473,000,000USD | -748,000,000USD | -769,000,000USD |
| Minority Interest | 1,000,000USD | 9,000,000USD | -41,000,000USD | 6,000,000USD | 9,000,000USD | 0USD | — | — |
| Net Income Applicable To Common Shares | 5,662,000,000USD | 5,980,000,000USD | 5,987,000,000USD | 6,025,000,000USD | 6,104,000,000USD | 4,572,000,000USD | 4,807,000,000USD | 3,750,000,000USD |
| Selling General Administrative | — | — | — | 7,453,000,000USD | 6,913,000USD | 17,450,000,000USD | 13,364,000,000USD | 14,020,000,000USD |
| Selling And Marketing Expenses | — | — | — | 10,233,000,000USD | — | — | — | — |
| Research Development | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 126,438,000,000USD | 125,827,000,000USD | 121,494,000,000USD | 122,749,000,000USD | 121,938,000,000USD | 119,717,000,000USD | 116,889,000,000USD | 116,533,000,000USD |
| Cash And Equivalents | 10,232,000,000USD | — | 9,491,000,000USD | 8,713,000,000USD | 8,560,000,000USD | 7,500,000,000USD | 8,288,000,000USD | — |
| Long Term Investments | 11,130,000,000USD | 28,530,000,000USD | 27,745,000,000USD | 28,614,000,000USD | 27,319,000,000USD | 27,212,000,000USD | 27,428,000,000USD | 30,960,000,000USD |
| Total Current Assets | 67,184,000,000USD | 67,032,000,000USD | 24,726,000,000USD | 23,370,000,000USD | 24,479,000,000USD | 23,105,000,000USD | 21,343,000,000USD | 20,210,000,000USD |
| Other Current Assets | 6,278,000,000USD | 8,681,000,000USD | -32,191,000,000USD | -57,345,000,000USD | -56,983,000,000USD | -55,118,000,000USD | -52,560,000,000USD | -55,219,000,000USD |
| Other Non Current Assets | 2,898,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 81,416,000,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 44,254,000,000USD | 45,309,000,000USD | 19,957,000,000USD | 18,077,000,000USD | 20,724,000,000USD | 20,345,000,000USD | 19,421,000,000USD | 19,599,000,000USD |
| Other Current Liabilities | 13,681,000,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 4,287,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 44,883,000,000USD | 43,902,000,000USD | 43,882,000,000USD | 43,953,000,000USD | 43,722,000,000USD | 42,503,000,000USD | 41,315,000,000USD | 43,775,000,000USD |
| Total Equity Including Noncontrolling Interest | 45,022,000,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 375,000,000USD | 1,074,000,000USD | 1,249,000,000USD | 929,000,000USD | 2,008,000,000USD | 1,893,000,000USD | 2,014,000,000USD | 2,460,000,000USD |
| Long Term Debt | 30,669,000,000USD | 30,768,000,000USD | 30,797,000,000USD | 31,173,000,000USD | 28,178,000,000USD | 28,110,000,000USD | 29,218,000,000USD | 24,688,000,000USD |
| Property Plant Equipment Net | 4,645,000,000USD | 4,657,000,000USD | 5,131,000,000USD | 4,657,000,000USD | 4,641,000,000USD | 4,617,000,000USD | 5,219,000,000USD | 4,505,000,000USD |
| Goodwill | 28,339,000,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 10,983,000,000USD | 11,093,000,000USD | 11,200,000,000USD | 11,327,000,000USD | 11,490,000,000USD | 11,940,000,000USD | 12,094,000,000USD | 10,325,000,000USD |
| Accounts Payable | 6,632,000,000USD | 6,209,000,000USD | 17,084,000,000USD | 17,148,000,000USD | 17,155,000,000USD | 16,812,000,000USD | 15,746,000,000USD | 15,346,000,000USD |
| Common Stock | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD |
| Retained Earnings | 36,675,000,000USD | 35,796,000,000USD | 35,393,000,000USD | 35,586,000,000USD | 35,549,000,000USD | 34,546,000,000USD | 33,549,000,000USD | 35,157,000,000USD |
| Accumulated Other Comprehensive Income | -711,000,000USD | -741,000,000USD | -451,000,000USD | -543,000,000USD | -760,000,000USD | -911,000,000USD | -1,147,000,000USD | -489,000,000USD |
| Total Liab | — | 81,785,000,000USD | 77,468,000,000USD | 78,667,000,000USD | 78,087,000,000USD | 77,097,000,000USD | 75,463,000,000USD | 72,654,000,000USD |
| Other Current Liab | — | 36,617,000,000USD | 22,702,000,000USD | -25,993,000,000USD | -28,002,000,000USD | -27,476,000,000USD | -26,195,000,000USD | -25,854,000,000USD |
| Capital Stock | — | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD |
| Good Will | — | 28,340,000,000USD | 28,344,000,000USD | 28,451,000,000USD | 28,368,000,000USD | 28,420,000,000USD | 28,277,000,000USD | 25,967,000,000USD |
| Cash | — | 9,657,000,000USD | 9,491,000,000USD | 8,713,000,000USD | 8,560,000,000USD | 7,500,000,000USD | 8,288,000,000USD | 7,866,000,000USD |
| Cash And Short Term Investments | — | 35,562,000,000USD | 9,491,000,000USD | 8,713,000,000USD | 8,560,000,000USD | 7,500,000,000USD | 8,288,000,000USD | 7,866,000,000USD |
| Current Deferred Revenue | — | 1,759,000,000USD | 1,493,000,000USD | 1,831,000,000USD | 1,561,000,000USD | 1,640,000,000USD | 1,508,000,000USD | 1,793,000,000USD |
| Net Debt | — | 22,185,000,000USD | 23,744,000,000USD | 23,389,000,000USD | 21,626,000,000USD | 22,503,000,000USD | 24,413,000,000USD | 19,282,000,000USD |
| Short Term Debt | — | 724,000,000USD | 1,380,000,000USD | 929,000,000USD | 2,008,000,000USD | 1,893,000,000USD | 2,167,000,000USD | 2,460,000,000USD |
| Short Long Term Debt Total | — | 31,842,000,000USD | 33,235,000,000USD | 32,102,000,000USD | 30,186,000,000USD | 30,003,000,000USD | 32,701,000,000USD | 27,148,000,000USD |
| Short Term Investments | — | 25,905,000,000USD | 25,884,000,000USD | 26,283,000,000USD | 25,298,000,000USD | 25,437,000,000USD | 25,201,000,000USD | 28,954,000,000USD |
| Net Receivables | — | 22,789,000,000USD | 15,235,000,000USD | 14,657,000,000USD | 15,919,000,000USD | 15,605,000,000USD | 13,055,000,000USD | 12,344,000,000USD |
| Common Stock Shares Outstanding | — | 220,400,000shares | 221,800,000shares | 225,800,000shares | 225,800,000shares | 227,200,000shares | 231,100,000shares | 233,100,000shares |
| Non Current Assets Total | — | 58,795,000,000USD | 96,768,000,000USD | 99,379,000,000USD | 97,459,000,000USD | 96,612,000,000USD | 95,546,000,000USD | 96,323,000,000USD |
| Non Current Liabilities Total | — | 36,476,000,000USD | 57,511,000,000USD | 60,590,000,000USD | 57,363,000,000USD | 56,752,000,000USD | 56,042,000,000USD | 53,055,000,000USD |
| Non Currrent Assets Other | — | 2,582,000,000USD | 13,211,000,000USD | 15,682,000,000USD | 15,175,000,000USD | 14,256,000,000USD | 12,573,000,000USD | 15,172,000,000USD |
| Unclassified Non Current Assets | — | -16,407,000,000USD | -110,357,000,000USD | -112,101,000,000USD | -111,472,000,000USD | -109,550,000,000USD | -106,934,000,000USD | -107,139,000,000USD |
| Unclassified Current Liabilities | — | -1,074,000,000USD | -23,951,000,000USD | -2,760,000,000USD | -2,008,000,000USD | -1,893,000,000USD | -2,014,000,000USD | -2,460,000,000USD |
| Unclassified Non Current Liabilities | — | 5,708,000,000USD | 26,714,000,000USD | 29,417,000,000USD | 29,185,000,000USD | 28,642,000,000USD | 26,824,000,000USD | 28,367,000,000USD |
| Unclassified Equity | — | 8,843,000,000USD | 8,936,000,000USD | 8,906,000,000USD | 8,929,000,000USD | 8,864,000,000USD | 8,909,000,000USD | 9,103,000,000USD |
| Other Assets | — | — | 121,494,000,000USD | 122,749,000,000USD | 121,938,000,000USD | 119,717,000,000USD | 116,889,000,000USD | 116,533,000,000USD |
| Unclassified Current Assets | — | — | -25,884,000,000USD | -26,283,000,000USD | -25,298,000,000USD | -25,437,000,000USD | -25,201,000,000USD | -28,954,000,000USD |
| Inventory | — | — | — | — | — | — | — | -11,190,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 121,494,000,000USD | 116,889,000,000USD | 108,928,000,000USD | 102,755,000,000USD | 97,460,000,000USD | 88,276,000,000USD | 78,254,000,000USD | 72,470,000,000USD |
| Intangible Assets | 11,200,000,000USD | 12,094,000,000USD | 10,273,000,000USD | 10,315,000,000USD | 10,615,000,000USD | 9,405,000,000USD | 8,674,000,000USD | 9,007,000,000USD |
| Other Current Assets | -32,191,000,000USD | -52,560,000,000USD | -54,005,000,000USD | -49,383,000,000USD | -30,016,000,000USD | -40,132,000,000USD | -35,004,000,000USD | -29,958,000,000USD |
| Total Liab | 77,468,000,000USD | 75,463,000,000USD | 69,523,000,000USD | 66,425,000,000USD | 61,332,000,000USD | 55,077,000,000USD | 46,526,000,000USD | 43,929,000,000USD |
| Total Stockholder Equity | 43,882,000,000USD | 41,315,000,000USD | 39,306,000,000USD | 36,243,000,000USD | 36,060,000,000USD | 33,199,000,000USD | 31,728,000,000USD | 28,541,000,000USD |
| Other Current Liab | 22,702,000,000USD | -26,195,000,000USD | -26,297,000,000USD | -24,080,000,000USD | -5,990,000,000USD | -18,811,000,000USD | -16,355,000,000USD | -15,309,000,000USD |
| Common Stock | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD |
| Capital Stock | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD | 3,000,000USD | 3,000,000USD | 3,000,000USD |
| Retained Earnings | 35,393,000,000USD | 33,549,000,000USD | 31,749,000,000USD | 29,647,000,000USD | 27,088,000,000USD | 23,802,000,000USD | 22,573,000,000USD | 19,988,000,000USD |
| Good Will | 28,344,000,000USD | 28,277,000,000USD | 25,317,000,000USD | 24,383,000,000USD | 24,228,000,000USD | 21,691,000,000USD | 20,500,000,000USD | 20,504,000,000USD |
| Other Assets | 121,494,000,000USD | 116,889,000,000USD | 108,928,000,000USD | 102,755,000,000USD | 97,460,000,000USD | 86,615,000,000USD | 77,453,000,000USD | 71,571,000,000USD |
| Cash | 9,491,000,000USD | 8,288,000,000USD | 6,526,000,000USD | 7,387,000,000USD | 4,880,000,000USD | 5,741,000,000USD | 4,937,000,000USD | 3,934,000,000USD |
| Cash And Equivalents | 9,491,000,000USD | 8,288,000,000USD | 6,526,000,000USD | 7,387,000,000USD | 4,880,000,000USD | 5,741,000,000USD | 4,937,000,000USD | 3,934,000,000USD |
| Cash And Short Term Investments | 9,491,000,000USD | 8,288,000,000USD | 6,526,000,000USD | 7,387,000,000USD | 4,880,000,000USD | 5,741,000,000USD | 4,937,000,000USD | 3,934,000,000USD |
| Total Current Assets | 24,726,000,000USD | 21,343,000,000USD | 18,986,000,000USD | 19,133,000,000USD | 14,571,000,000USD | 13,869,000,000USD | 12,521,000,000USD | 10,677,000,000USD |
| Total Current Liabilities | 19,957,000,000USD | 19,421,000,000USD | 19,551,000,000USD | 18,654,000,000USD | 15,525,000,000USD | 12,169,000,000USD | 11,298,000,000USD | 9,448,000,000USD |
| Current Deferred Revenue | 1,493,000,000USD | 1,508,000,000USD | 1,402,000,000USD | 1,112,000,000USD | 1,153,000,000USD | 1,259,000,000USD | 1,017,000,000USD | 902,000,000USD |
| Net Debt | 23,744,000,000USD | 24,413,000,000USD | 20,128,000,000USD | 18,410,000,000USD | 20,012,000,000USD | 16,098,000,000USD | 16,270,000,000USD | 15,277,000,000USD |
| Short Term Debt | 1,380,000,000USD | 2,167,000,000USD | 2,038,000,000USD | 1,946,000,000USD | 2,007,000,000USD | 810,000,000USD | 2,456,000,000USD | 1,994,000,000USD |
| Short Long Term Debt | 1,249,000,000USD | 2,014,000,000USD | 1,874,000,000USD | 1,765,000,000USD | 1,874,000,000USD | 700,000,000USD | 2,298,000,000USD | 1,994,000,000USD |
| Short Long Term Debt Total | 33,235,000,000USD | 32,701,000,000USD | 26,654,000,000USD | 25,797,000,000USD | 24,892,000,000USD | 21,839,000,000USD | 21,207,000,000USD | 19,211,000,000USD |
| Long Term Debt | 30,797,000,000USD | 29,218,000,000USD | 23,246,000,000USD | 22,349,000,000USD | 21,157,000,000USD | 19,335,000,000USD | 17,787,000,000USD | 17,217,000,000USD |
| Long Term Investments | 27,745,000,000USD | 27,428,000,000USD | 30,719,000,000USD | 27,657,000,000USD | 28,780,000,000USD | 4,847,000,000USD | 4,733,000,000USD | 4,213,000,000USD |
| Short Term Investments | 25,884,000,000USD | 25,201,000,000USD | 29,614,000,000USD | 25,952,000,000USD | 26,267,000,000USD | 23,433,000,000USD | 19,676,000,000USD | 16,713,000,000USD |
| Net Receivables | 15,235,000,000USD | 13,055,000,000USD | 12,460,000,000USD | 11,746,000,000USD | 9,691,000,000USD | 8,128,000,000USD | 7,584,000,000USD | 6,743,000,000USD |
| Accounts Payable | 17,084,000,000USD | 15,746,000,000USD | 16,111,000,000USD | 15,596,000,000USD | 13,518,000,000USD | 11,359,000,000USD | 8,842,000,000USD | 7,454,000,000USD |
| Property Plant Equipment Net | 5,131,000,000USD | 5,219,000,000USD | 4,943,000,000USD | 4,920,000,000USD | 4,547,000,000USD | 4,129,000,000USD | 3,708,000,000USD | 2,735,000,000USD |
| Accumulated Other Comprehensive Income | -451,000,000USD | -1,147,000,000USD | -1,313,000,000USD | -2,490,000,000USD | -178,000,000USD | 150,000,000USD | -296,000,000USD | -986,000,000USD |
| Common Stock Shares Outstanding | 221,800,000shares | 232,900,000shares | 237,400,000shares | 242,800,000shares | 246,800,000shares | 254,300,000shares | 260,300,000shares | 254,300,000shares |
| Non Current Assets Total | 96,768,000,000USD | 95,546,000,000USD | 89,942,000,000USD | 83,622,000,000USD | 82,889,000,000USD | 74,407,000,000USD | 65,733,000,000USD | 61,793,000,000USD |
| Non Current Liabilities Total | 57,511,000,000USD | 56,042,000,000USD | 49,972,000,000USD | 47,771,000,000USD | 45,807,000,000USD | 42,908,000,000USD | 35,228,000,000USD | 34,481,000,000USD |
| Non Currrent Assets Other | 13,211,000,000USD | 12,573,000,000USD | 12,355,000,000USD | 10,525,000,000USD | 9,391,000,000USD | 7,682,000,000USD | 6,589,000,000USD | 6,196,000,000USD |
| Unclassified Current Assets | -25,884,000,000USD | -25,201,000,000USD | -29,614,000,000USD | -25,952,000,000USD | -26,267,000,000USD | -23,433,000,000USD | -19,676,000,000USD | -16,713,000,000USD |
| Unclassified Non Current Assets | -110,357,000,000USD | -106,934,000,000USD | -102,593,000,000USD | -96,933,000,000USD | -92,132,000,000USD | -59,962,000,000USD | -55,924,000,000USD | -52,433,000,000USD |
| Unclassified Current Liabilities | -23,951,000,000USD | -2,014,000,000USD | -1,874,000,000USD | -1,765,000,000USD | -3,027,000,000USD | -1,959,000,000USD | -3,315,000,000USD | -2,896,000,000USD |
| Unclassified Non Current Liabilities | 26,714,000,000USD | 26,824,000,000USD | 26,726,000,000USD | 17,507,000,000USD | 14,223,000,000USD | 14,317,000,000USD | 9,281,000,000USD | 9,568,000,000USD |
| Unclassified Equity | 8,936,000,000USD | 8,909,000,000USD | 8,866,000,000USD | 9,082,000,000USD | 9,146,000,000USD | 9,241,000,000USD | 9,445,000,000USD | 9,533,000,000USD |
| Inventory | — | — | -46,332,000,000USD | -11,381,000,000USD | -38,483,000,000USD | -34,331,000,000USD | -29,051,000,000USD | -25,551,000,000USD |
| Deferred Long Term Liab | — | — | — | 2,034,000,000USD | 2,805,000,000USD | 2,019,000,000USD | 2,227,000,000USD | 1,960,000,000USD |
| Other Liab | — | — | — | 3,582,000,000USD | 5,137,000,000USD | 4,628,000,000USD | 3,839,000,000USD | 3,848,000,000USD |
| Non Current Liabilities Other | — | — | — | 2,299,000,000USD | 2,485,000,000USD | 2,609,000,000USD | 2,094,000,000USD | 1,888,000,000USD |
| Net Tangible Assets | — | — | — | 1,609,000,000USD | 1,217,000,000USD | 2,103,000,000USD | 2,554,000,000USD | -970,000,000USD |
| Property Plant Equipment Gross | — | — | — | — | — | 3,483,000,000USD | 3,133,000,000USD | 2,735,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Net Income | 3,214,000,000USD |
| Depreciation | 720,000,000USD |
| Stock Based Compensation | 130,000,000USD |
| Deferred Income Tax | -123,000,000USD |
| Other Non Cash Items | -399,000,000USD |
| Change To Account Receivables | -1,831,000,000USD |
| Change To Liabilities | 5,487,000,000USD |
| Change In Working Capital | 2,703,000,000USD |
| Operating Cash Flow | 6,245,000,000USD |
| Capital Expenditures | -522,000,000USD |
| Net Investments | -813,000,000USD |
| Other Investing Activities | -528,000,000USD |
| Unclassified Investing Cash Flow | -142,000,000USD |
| Investing Cash Flow | -1,483,000,000USD |
| Net Debt Issuance | -900,000,000USD |
| Common Stock Issuance | 63,000,000USD |
| Net Common Stock Issuance | -1,330,000,000USD |
| Common Dividends Paid | -749,000,000USD |
| Unclassified Financing Cash Flow | -1,030,000,000USD |
| Financing Cash Flow | -4,009,000,000USD |
| Effect Of Forex Changes On Cash | -12,000,000USD |
| Change In Cash | 741,000,000USD |
| End Cash Flow | 10,232,000,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 1,760,000,000USD | 546,000,000USD | 1,187,000,000USD | 1,744,000,000USD | 2,184,000,000USD | 413,000,000USD | 1,008,000,000USD | 2,301,000,000USD |
| Depreciation | 354,000,000USD | 406,000,000USD | 387,000,000USD | 380,000,000USD | 373,000,000USD | 398,000,000USD | 329,000,000USD | 335,000,000USD |
| Stock Based Compensation | 55,000,000USD | 30,000,000USD | 84,000,000USD | 81,000,000USD | 81,000,000USD | -29,000,000USD | 66,000,000USD | 92,000,000USD |
| Other Non Cash Items | 1,381,000,000USD | -52,000,000USD | -42,000,000USD | 119,000,000USD | 338,000,000USD | 58,000,000USD | 256,000,000USD | -156,000,000USD |
| Change To Account Receivables | -1,174,000,000USD | 756,000,000USD | 815,000,000USD | -923,000,000USD | -3,174,000,000USD | -193,000,000USD | 851,000,000USD | -1,059,000,000USD |
| Change In Working Capital | 1,056,000,000USD | -524,000,000USD | -750,000,000USD | -218,000,000USD | -1,785,000,000USD | -18,000,000USD | 1,242,000,000USD | -1,955,000,000USD |
| Total Cash From Operating Activities | 4,332,000,000USD | 84,000,000USD | 1,135,000,000USD | 2,054,000,000USD | 1,017,000,000USD | 706,000,000USD | 2,677,000,000USD | 447,000,000USD |
| Capital Expenditures | -235,000,000USD | -293,000,000USD | -360,000,000USD | -267,000,000USD | -196,000,000USD | -322,000,000USD | -332,000,000USD | -323,000,000USD |
| Free Cash Flow | 4,097,000,000USD | -209,000,000USD | 775,000,000USD | 1,787,000,000USD | 821,000,000USD | 384,000,000USD | 2,345,000,000USD | 124,000,000USD |
| Investments | -1,089,000,000USD | 481,000,000USD | -1,224,000,000USD | -687,000,000USD | 103,000,000USD | -1,638,000,000USD | -401,000,000USD | -818,000,000USD |
| Total Cashflows From Investing Activities | -1,642,000,000USD | 464,000,000USD | -1,224,000,000USD | -687,000,000USD | 103,000,000USD | -1,638,000,000USD | -401,000,000USD | -818,000,000USD |
| Net Borrowings | -1,328,000,000USD | 1,591,000,000USD | 1,360,000,000USD | 195,000,000USD | -819,000,000USD | 3,819,000,000USD | -358,000,000USD | — |
| Total Cash From Financing Activities | -2,515,000,000USD | 236,000,000USD | 243,000,000USD | -308,000,000USD | -1,909,000,000USD | 1,408,000,000USD | -915,000,000USD | 668,000,000USD |
| Dividends Paid | -376,000,000USD | -377,000,000USD | -381,000,000USD | -385,000,000USD | -386,000,000USD | -373,000,000USD | -378,000,000USD | -378,000,000USD |
| Sale Purchase Of Stock | -1,124,000,000USD | -471,000,000USD | -876,000,000USD | -378,000,000USD | -880,000,000USD | -1,811,000,000USD | -60,000,000USD | -463,000,000USD |
| Change In Cash | 166,000,000USD | 778,000,000USD | 153,000,000USD | 1,060,000,000USD | -788,000,000USD | 422,000,000USD | 1,369,000,000USD | 271,000,000USD |
| Begin Period Cash Flow | 9,491,000,000USD | 8,713,000,000USD | 8,560,000,000USD | 7,500,000,000USD | 8,288,000,000USD | 7,866,000,000USD | 6,497,000,000USD | 6,226,000,000USD |
| End Period Cash Flow | 9,657,000,000USD | 9,491,000,000USD | 8,713,000,000USD | 8,560,000,000USD | 7,500,000,000USD | 8,288,000,000USD | 7,866,000,000USD | 6,497,000,000USD |
| Other Cashflows From Investing Activities | -323,000,000USD | 243,000,000USD | -123,000,000USD | -189,000,000USD | -315,000,000USD | 205,000,000USD | 130,000,000USD | -145,000,000USD |
| Other Cashflows From Financing Activities | -291,000,000USD | -565,000,000USD | 140,000,000USD | 262,000,000USD | 176,000,000USD | -227,000,000USD | -119,000,000USD | 112,000,000USD |
| Unclassified Operating Cash Flow | -274,000,000USD | -322,000,000USD | 269,000,000USD | -52,000,000USD | -174,000,000USD | -116,000,000USD | -224,000,000USD | -170,000,000USD |
| Unclassified Financing Cash Flow | 604,000,000USD | 58,000,000USD | — | — | — | — | — | 1,397,000,000USD |
| Unclassified Investing Cash Flow | — | 33,000,000USD | 483,000,000USD | 456,000,000USD | 511,000,000USD | 117,000,000USD | 202,000,000USD | 468,000,000USD |
| Change To Inventory | — | — | — | — | — | — | -282,000,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 5,661,000,000USD | 5,971,000,000USD | 5,987,000,000USD | 6,095,000,000USD | 4,572,000,000USD | 4,807,000,000USD | 3,750,000,000USD | 3,842,800,000USD |
| Depreciation | 1,546,000,000USD | 1,393,000,000USD | 1,745,000,000USD | 1,302,000,000USD | 1,154,000,000USD | 1,133,000,000USD | 1,127,000,000USD | 890,400,000USD |
| Stock Based Compensation | 276,000,000USD | 191,000,000USD | 289,000,000USD | 255,000,000USD | 283,000,000USD | 294,000,000USD | 226,000,000USD | 169,600,000USD |
| Other Non Cash Items | 363,000,000USD | 346,000,000USD | 1,177,000,000USD | -245,000,000USD | 16,000,000USD | -62,000,000USD | 235,000,000USD | 186,200,000USD |
| Change To Account Receivables | -2,526,000,000USD | -683,000,000USD | -1,762,000,000USD | -2,138,000,000USD | -256,000USD | -1,053,000,000USD | -707,000,000USD | -22,200,000USD |
| Change In Working Capital | -3,277,000,000USD | -1,719,000,000USD | -535,000,000USD | 784,000,000USD | 5,203,000,000USD | -192,000,000USD | -1,602,000,000USD | 367,900,000USD |
| Total Cash From Operating Activities | 4,290,000,000USD | 5,808,000,000USD | 8,061,000,000USD | 8,364,000,000USD | 10,688,000,000USD | 6,061,000,000USD | 3,827,000,000USD | 4,184,800,000USD |
| Capital Expenditures | -1,116,000,000USD | -1,256,000,000USD | -1,296,000,000USD | -1,087,000,000USD | -1,021,000,000USD | -1,077,000,000USD | -1,208,000,000USD | -790,200,000USD |
| Free Cash Flow | 3,174,000,000USD | 4,552,000,000USD | 6,765,000,000USD | 7,277,000,000USD | 9,667,000,000USD | 4,984,000,000USD | 2,619,000,000USD | 3,394,600,000USD |
| Investments | 69,000,000USD | -5,167,000,000USD | -4,254,000,000USD | -4,056,000,000USD | -14,751,000,000USD | -2,458,000,000USD | 16,000,000USD | -2,849,000,000USD |
| Total Cashflows From Investing Activities | -1,344,000,000USD | -5,167,000,000USD | -5,572,000,000USD | -9,638,000,000USD | -7,324,000,000USD | -2,792,000,000USD | -1,259,000,000USD | -5,082,400,000USD |
| Net Borrowings | 2,327,000,000USD | 5,562,000,000USD | 739,000,000USD | 3,675,000,000USD | -298,000,000USD | 438,000,000USD | -1,295,000,000USD | 3,724,200,000USD |
| Total Cash From Financing Activities | -1,738,000,000USD | 1,193,000,000USD | -3,349,000,000USD | 423,000,000USD | -2,567,000,000USD | -2,266,000,000USD | -2,241,000,000USD | 426,900,000USD |
| Dividends Paid | -1,529,000,000USD | -1,508,000,000USD | -1,395,000,000USD | -1,104,000,000USD | -954,000,000USD | -818,000,000USD | -776,000,000USD | -704,900,000USD |
| Sale Purchase Of Stock | -2,605,000,000USD | -2,900,000,000USD | -2,676,000,000USD | -1,900,000,000USD | -2,700,000,000USD | -1,701,000,000USD | -1,685,000,000USD | -1,997,700,000USD |
| Change In Cash | 1,203,000,000USD | 1,762,000,000USD | -861,000,000USD | -861,000,000USD | 804,000,000USD | 1,003,000,000USD | 325,000,000USD | -466,400,000USD |
| Begin Period Cash Flow | 8,288,000,000USD | 6,526,000,000USD | 7,387,000,000USD | 5,741,000,000USD | 4,937,000,000USD | 3,934,000,000USD | 3,609,000,000USD | 4,075,300,000USD |
| End Period Cash Flow | 9,491,000,000USD | 8,288,000,000USD | 6,526,000,000USD | 4,880,000,000USD | 5,741,000,000USD | 4,937,000,000USD | 3,934,000,000USD | 3,608,900,000USD |
| Other Cashflows From Investing Activities | -385,000,000USD | -51,000,000USD | -24,000,000USD | -1,019,000,000USD | 8,448,000,000USD | 743,000,000USD | -220,000,000USD | 636,400,000USD |
| Other Cashflows From Financing Activities | 69,000,000USD | 39,000,000USD | -17,000,000USD | -451,000,000USD | 360,000,000USD | -119,000,000USD | -181,000,000USD | -594,200,000USD |
| Unclassified Operating Cash Flow | -279,000,000USD | -374,000,000USD | -602,000,000USD | 173,000,000USD | -540,000,000USD | 81,000,000USD | 91,000,000USD | -1,272,100,000USD |
| Unclassified Investing Cash Flow | 88,000,000USD | 1,307,000,000USD | — | -3,476,000,000USD | — | — | 153,000,000USD | -2,079,600,000USD |
| Change To Inventory | — | — | 1,762,000,000USD | 2,138,000,000USD | 256,000,000USD | 593,000,000USD | -1,099,000,000USD | -53,100,000USD |
| Change To Liabilities | — | — | — | 606,000,000USD | 5,780,000,000USD | 1,171,000,000USD | -675,000,000USD | 1,219,200,000USD |
| Exchange Rate Changes | — | — | — | -10,000,000USD | 7,000,000USD | — | -2,000,000USD | 4,300,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -861,000,000USD | 804,000,000USD | 1,003,000,000USD | 325,000,000USD | -466,400,000USD |
| Unclassified Financing Cash Flow | — | — | — | 203,000,000USD | 1,025,000,000USD | -66,000,000USD | 1,696,000,000USD | — |
| Issuance Of Capital Stock | — | — | — | — | 0USD | 0USD | 1,250,000,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
Benefit Expense Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 89.7 | percent | Disclosure |
Benefit Expense Ratio - Year to Date
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 88.3 | percent | Disclosure |
BlueCard Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 6,582,000 | members | Disclosure |
Carelon Services Consumers Served
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 92,400,000 | consumers | Disclosure |
CarelonRx Quarterly Adjusted Scripts
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 80,900,000 | adjusted scripts | Disclosure |
Commercial Fee-Based Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 27,513,000 | members | Disclosure |
Commercial Risk-Based Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 4,734,000 | members | Disclosure |
Current-Year Medical Claims Paid Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 78.9 | percent | Disclosure |
Dental Administration Members
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 1,940,000 | members | Disclosure |
Dental Members
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 7,480,000 | members | Disclosure |
Employer Group Fee-Based Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 20,931,000 | members | Disclosure |
Employer Group Risk-Based Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 3,417,000 | members | Disclosure |
Federal Employee Program Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 1,554,000 | members | Disclosure |
Individual Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 1,317,000 | members | Disclosure |
Medicaid Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 8,358,000 | members | Disclosure |
Medicare Advantage Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 1,897,000 | members | Disclosure |
Medicare Advantage Members in 4-Star or Higher Plans
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 59 | percent | Disclosure |
Medicare Part D Standalone Members
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 78,000 | members | Disclosure |
Medicare Supplement Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 893,000 | members | Disclosure |
Operating Expense Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | quarterly | 11.1 | percent | Disclosure |
Operating Expense Ratio - Year to Date
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 12 | percent | Disclosure |
Prior-Year Redundancy to Adjusted Payable Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 7.7 | percent | Disclosure |
Prior-Year Redundancy to Prior-Year Incurred Claims Ratio
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | year_to_date | 0.8 | percent | Disclosure |
Total Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 44,949,000 | members | Disclosure |
Total Medicare Medical Membership
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 2,790,000 | members | Disclosure |
Vision Members
| Period end | Period | Value | Unit | Source |
|---|---|---|---|---|
| 2026-06-30 | instant | 11,912,000 | members | Disclosure |
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.